These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19382155)

  • 1. Coronary heart disease of females: lessons learned from nonhuman primates.
    Clarkson TB; Mehaffey MH
    Am J Primatol; 2009 Sep; 71(9):785-93. PubMed ID: 19382155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies about HRT--lessons from monkey models.
    Clarkson TB; Appt SE
    Maturitas; 2005 May; 51(1):64-74. PubMed ID: 15883111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.
    Clarkson TB
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):147S-151S. PubMed ID: 7958009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB
    Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of estrogen treatment on arterial wall structure and function.
    Clarkson TB; Anthony MS; Klein KP
    Drugs; 1994; 47 Suppl 2():42-51. PubMed ID: 7517833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2007; 14(3 Pt 1):373-84. PubMed ID: 17438515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women.
    Wagner JD; Clarkson TB
    Semin Reprod Med; 2005 May; 23(2):149-56. PubMed ID: 15852200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social behavior and gender in biomedical investigations using monkeys: studies in atherogenesis.
    Kaplan JR; Adams MR; Clarkson TB; Manuck SB; Shively CA
    Lab Anim Sci; 1991 Aug; 41(4):334-43. PubMed ID: 1658480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial influences on the pathogenesis of atherosclerosis among nonhuman primates.
    Clarkson TB; Kaplan JR; Adams MR; Manuck SB
    Circulation; 1987 Jul; 76(1 Pt 2):I29-40. PubMed ID: 3297407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of exogenous oestrogen in inhibiting stress-related coronary artery atherosclerosis.
    Clarkson TB; Kaplan JR; Shively CA; Klein KP
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():73-8; discussion 78-9. PubMed ID: 8624347
    [No Abstract]   [Full Text] [Related]  

  • 13. Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Tremollières F; Terrisse AD; Sié P; Payrastre B; Guery JC; Bayard F; Gourdy P
    Arch Mal Coeur Vaiss; 2007; 100(6-7):554-62. PubMed ID: 17893638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undertreatment of menopausal symptoms and novel options for comprehensive management.
    Lewis V
    Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique value of primate models in translational research. Nonhuman primate models of women's health: introduction and overview.
    Shively CA; Clarkson TB
    Am J Primatol; 2009 Sep; 71(9):715-21. PubMed ID: 19507247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions.
    Ouyang P; Michos ED; Karas RH
    J Am Coll Cardiol; 2006 May; 47(9):1741-53. PubMed ID: 16682298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen protection against coronary heart disease: are the relevant effects of estrogen mediated through its effects on uterus--such as the induction of menstruation, increased bleeding, and the facilitation of pregnancy?
    Paranjape SG; Turankar AV; Wakode SL; Dakhale GN
    Med Hypotheses; 2005; 65(4):725-7. PubMed ID: 15950396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models.
    Kaplan JR; Adams MR; Clarkson TB; Manuck SB; Shively CA; Williams JK
    Psychosom Med; 1996; 58(6):598-611. PubMed ID: 8948008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen is a modulator of vascular inflammation.
    Chakrabarti S; Lekontseva O; Davidge ST
    IUBMB Life; 2008 Jun; 60(6):376-82. PubMed ID: 18409173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.